Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Oxidative DNA damage in chronic renal failure patients
Nephrology Dialysis Transplantation, 11/05/09
Stoyanova E et al. – Genetic damage increases when renal function decreases, being maximum in haemodialysis patients. Although part of the observed damage can be attributed to the uraemic state itself, other individual genetic factors can influence a state of genomic instability responsible for the observed genomic damage.
Related Articles
Acute renal failure associated with the rift valley fever: A single center study
Saudi Journal of Kidney Diseases and Transplantation, 11/09/09
Relevance Score: 70%
Acute Renal Failure Associated with Acute Non-fulminant Hepatitis A: A Case Report and Review of Literature
Renal Failure, 10/30/09
Relevance Score: 69%
A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09
Relevance Score: 69%
Acute renal failure from nitrofurantoin-induced acute granulomatous interstitial nephritis
QJM: An International Journal of Medicine, 10/16/09
Relevance Score: 69%
Interindividual variability of drug transporters: Impact on opioid treatment in chronic renal failure
European Journal of Pain, 11/12/09
Relevance Score: 68%
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Journal of Clinical Oncology, 12/09/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


